{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "6903114", "DateCompleted": {"Year": "1980", "Month": "11", "Day": "25"}, "DateRevised": {"Year": "2014", "Month": "11", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0003-0805", "JournalIssue": {"Volume": "121", "Issue": "6", "PubDate": {"Year": "1980", "Month": "Jun"}}, "Title": "The American review of respiratory disease", "ISOAbbreviation": "Am Rev Respir Dis"}, "ArticleTitle": "Ozone inactivation of human alpha 1-proteinase inhibitor.", "Pagination": {"StartPage": "1031", "EndPage": "1038", "MedlinePgn": "1031-8"}, "Abstract": {"AbstractText": ["Ozone decreased the trypsin, chymotrypsin, and elastase inhibitory activities of human alpha 1-proteinase inhibitor (alpha 1-PI) both in plasma and in solutions of the pure inhibitor. The total loss of porcine elastase inhibitory activity required 18 mol of ozone/mol of pure alpha 1-PI and approximately 850 mol of ozone/mol of alpha 1-PI in plasma. A corresponding loss of the ability to inhibit human leukocyte elastase was observed. Inactivated alpha 1-PI contains four residues of methionine sulfoxide, in addition to oxidized tyrosine and tryptophan. Electrophoretic analysis demonstrated that the ozone-inactivated alpha 1-PI did not form normal complexes witrh serine proteinases. These findings suggest that the inhalation of ozone could inactivate alpha 1-PI on the airspace side of the lung to create a localized alpha 1-PI deficiency, which might contribute to the development of emphysema."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Johnson", "ForeName": "D A", "Initials": "DA"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am Rev Respir Dis", "NlmUniqueID": "0370523", "ISSNLinking": "0003-0805"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amino Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "8DUH1N11BX", "NameOfSubstance": "Tryptophan"}, {"RegistryNumber": "AE28F7PNPL", "NameOfSubstance": "Methionine"}, {"RegistryNumber": "EC 3.4.21.1", "NameOfSubstance": "Chymotrypsin"}, {"RegistryNumber": "EC 3.4.21.36", "NameOfSubstance": "Pancreatic Elastase"}], "MeshHeadingList": [{"QualifierName": ["analysis"], "DescriptorName": "Amino Acids"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Chymotrypsin"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": ["metabolism"], "DescriptorName": "Methionine"}, {"QualifierName": [], "DescriptorName": "Oxidation-Reduction"}, {"QualifierName": ["pharmacology", "toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Pancreatic Elastase"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Pulmonary Emphysema"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tryptophan"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1980", "Month": "6", "Day": "1"}, {"Year": "1980", "Month": "6", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1980", "Month": "6", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["6903114", "10.1164/arrd.1980.121.6.1031"]}}], "PubmedBookArticle": []}